Journal of Clinical Microbiology · 2003 · 22 citations · 15 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceDiagnostic MicrobiologyMedical MicrobiologyAntibacterial ResistanceAntibiotic ResistanceAntimicrobial Susceptibility TestingResistance In Gram-positive BacteriaAntibacterial Susceptibility TestingAntibiotic Susceptibility TestingAntimicrobial Susceptibility InterpretationAntimicrobial Susceptibility Testing CorrelatesDisk Diffusion TestingPathogen Resistance TestingPseudomonas Aeruginosa ResistanceResistance In Clinical Isolates
Susceptibility to piperacillin was similar to that to piperacillin-tazobactam (<1% difference) for 6,938 isolates of Enterobacter aerogenes and 13,954 isolates of Enterobacter cloacae tested using a Vitek system; for the same species, in contrast, susceptibility rates to piperacillin-tazobactam were 5.9 to 13.9% higher than to piperacillin using disk diffusion, MicroScan, and Vitek 2 testing. Unprecedented phenotypes (piperacillin susceptible and piperacillin-tazobactam intermediate; piperacillin intermediate and piperacillin-tazobactam resistant; piperacillin susceptible and piperacillin-tazobactam resistant) accounted for 6.1% of the results for E. aerogenes isolates and 6.0% of the results for E. cloacae isolates tested with the Vitek system.
15
Michael A. Pfaller, Robert N. Jones, Mondell L. Beach · Clinical Infectious Diseases · 1999 · 315 citations · Full text
Ana Cristina Gales, Robert N. Jones, John Turnidge et al. · Clinical Infectious Diseases · 2001 · 311 citations
Ronald N. Jones, Kari C. Kugler, Michael A. Pfaller et al. · Diagnostic Microbiology and Infectious Disease · 1999 · 155 citations